Shares of EnteroMedics have been on a tear since the January 5th announcement about the availability of its VBLOC neurometabolic therapy for the treatment of obesity at two additional institutes.
from RTT - Biotech http://ift.tt/2iykT3n
via IFTTT
No comments:
Post a Comment